Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
03/2007
03/06/2007US7186503 Compounds and methods for modulating activation of NF-κB
03/06/2007US7186459 Holding capability for hydrophilic and lipophilic drugs, water-soluble and hydrophobic substaces; controlling sustained release
03/06/2007CA2320488C Strategically modified hepatitis b core proteins and their derivatives
03/06/2007CA2252366C Enhancement of gene expression
03/06/2007CA2240393C Method for producing temperature-tolerant plants
03/06/2007CA2189131C Use of pteridine derivatives as no-synthase inhibitors
03/06/2007CA2109221C Production of polyhydroxyalkanoate in plants
03/01/2007WO2007024739A2 Herbicide resistance gene, compositions and methods
03/01/2007WO2007024207A1 Enhanced zein reduction in transgenic corn seed
03/01/2007WO2007023973A1 Cysteine synthase gene and use thereof
03/01/2007WO2007023969A2 O-acetylhomoserinesulfhydorelace gene and use thereof
03/01/2007WO2007023602A1 Novel enzyme, method of producing the same and method of producing monoacetylpolyamine by using the enzyme
03/01/2007WO2007023369A1 Modified expandase-hydroxylase and its applications
03/01/2007WO2007023287A1 Vectors and uses thereof
03/01/2007WO2007022668A1 Important lymphocyte activation regulatory protein pkd2 and uses thereof
03/01/2007WO2007022598A1 Enhancing enzyme production
03/01/2007WO2007022597A1 Extracting and purifying limit dextrinases
03/01/2007WO2006110188A3 Genes conferring herbicide resistance
03/01/2007WO2006086730A3 Inhibiting her2 shedding with matrix metalloprotease antagonists
03/01/2007WO2006084470A3 Enzymatic enantioselective ester or amide hydrolysis or synthesis
03/01/2007WO2006083240A3 Microbially expressed xylanases and their use as feed additives and other uses
03/01/2007WO2006040358A3 Homologous amds genes as selectable marker
03/01/2007WO2006009924A3 Pfks as modifiers of the igfr pathway and methods of use
03/01/2007WO2005094485A3 Drug screening
03/01/2007WO2005011610A3 Neurodegenerative protein aggregation inhibition methods and compounds
03/01/2007WO2004084806A3 Protein modification and maintenance molecules
03/01/2007WO2004081180A3 Crystals and structures of ephrin reception epha7
03/01/2007US20070050865 Polynucleotide encoding 2-hydorxyisoflavanone dehydratase and application of the same
03/01/2007US20070050863 Herbicide Resistance Gene, Compositions and Methods
03/01/2007US20070050858 Inactive ca2+/calmodulin-dependent protein kinase II-alpha knockin animal and knockin cell of the same
03/01/2007US20070050856 Use of protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
03/01/2007US20070049744 Glucosyltransferases
03/01/2007US20070049736 Cytokine receptor specific immunoglobulin for prevention and treatment of infection, cell proliferative and autoimmune disorders
03/01/2007US20070049544 Antisense IAP nucleobase oligomers and uses thereof
03/01/2007US20070049532 Selecting by phage display a peptide that binds to nerve growth factor (NGF), and preparing a fusion protein with an Fc domain; biological half-life increases
03/01/2007US20070048855 comprising a mutant Rhodosporidium toruloides PAL; for preventing or treating diseases associated with a phenylalanine imbalance in a human or animal body
03/01/2007US20070048854 Obtained from Campylobacter species; for use in synthesis of lipooligosaccharide (LOS); ganglioside biosynthesis and mimetics for treatment of nervous system disorders
03/01/2007US20070048853 Carnitine palmitoyltransferase II crystals
03/01/2007US20070048852 Directed selective solid-phase culturing of stable microbial mixed populations for the continuous preparation of defined enzyme and metabolite mixtures
03/01/2007US20070048849 Contacting glycerol or 1,3-dihydroxyacetone with a single recombinant yeast or filamentous fungi expressing an exogenous glycerol dehydratase enzyme from Klebsiella or Citrobacter; fermentation
03/01/2007US20070048841 Viricidal polypeptide for prevention and treatment of hepatitis infection
03/01/2007US20070048839 Novel amylolytic enzyme extracted from bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme
03/01/2007US20070048838 Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method
03/01/2007US20070048814 Novel Purified dihydrodipicolinate synthase polypeptides and structures thereof
03/01/2007US20070048811 Tumor suppressor designated TS10q23.3
03/01/2007US20070048784 Novel human hydrolase family members and uses thereof
03/01/2007US20070048774 Continuous in-vitro evolution
03/01/2007US20070048772 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases
03/01/2007US20070048748 Mutant polymerases for sequencing and genotyping
03/01/2007US20070048740 Full-length cDNA
03/01/2007US20070048331 Non-toxic mutants of pathogenic gram-negative bacteria
03/01/2007US20070048322 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
03/01/2007US20070048286 Method of treating dopaminergic and GABA-nergic disorders
03/01/2007US20070045193 Weakly acidic cation exchangers
03/01/2007DE19960225B4 Kristallines, in der asymmetrischen Einheit mindestens eine an der Katalyse beteiligte (Sub)-Domaine eines humanen m-Calpains aufweisendes Polypeptid, Verfahren zur Identifizierung von Verbindungen unter dessen Verwendung, Verfahren zu dessen Kristallisation und Verfahren zur Darstellung einer 3-dimensionalen Struktur dieses Peptids Crystalline, in the asymmetric unit, at least one involved in catalysis (Sub) -Domaine a human m-calpain polypeptide having, methods for identifying compounds with its use, method of crystallization and method for displaying a 3-dimensional structure of this peptide
03/01/2007CA2620903A1 Ply-gbs mutant lysins
03/01/2007CA2619521A1 Aggrecanase structure
03/01/2007CA2602486A1 Cysteine synthase gene and use thereof
03/01/2007CA2602425A1 O-acetylhomoserinesulfhydorelace gene and use thereof
03/01/2007CA2583501A1 Enhanced zein reduction in transgenic corn seed
02/2007
02/28/2007EP1757700A2 Cell culture process for glycoproteins
02/28/2007EP1757699A1 cDNAs encoding secreted proteins
02/28/2007EP1757698A1 Polypeptides having dna polymerase activity
02/28/2007EP1757696A2 Group B streptococcus proteins, and their use
02/28/2007EP1757685A1 Modified ethylenediamine-n,n' disuccinic acid:ethylenediamine lyase
02/28/2007EP1757684A2 A 2,6-beta-D-fructan hydrolase enzyme and processes for using the enzyme
02/28/2007EP1757683A1 Method of making a mutated type IIT endonuclease which has nicking activity
02/28/2007EP1757682A1 Es cell mutation method and system
02/28/2007EP1757621A2 Compositions and methods for the treatment and diagnosis of immune disorders
02/28/2007EP1756740A1 Crystal structure of dipeptidyl peptidase iv (dpp-iv) and uses thereof
02/28/2007EP1756352A1 New enzymatic bleaching system
02/28/2007EP1756291A2 Enzymatic decarboxylation of 2-keto-l-gulonic acid to produce xylose
02/28/2007EP1756284A1 Method for modifying plant morphology, biochemistry and physiology comprising expression of cytokinin oxidase in the seeds
02/28/2007EP1756281A2 Method for the preparation of optically active epoxides and vicinal diols from styrene epoxides using enantioselective epoxide hydrolases derived from yeasts
02/28/2007EP1756280A1 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
02/28/2007EP1756275A1 Method for obtaining mature protease by enzymatic digestion
02/28/2007EP1756274A1 Lipolytic enzyme assay
02/28/2007EP1756273A1 Signal peptide for producing a polypeptide
02/28/2007EP1756272A2 Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation
02/28/2007EP1756271A2 Methods for obtaining optically active epoxides and vicinal diols from 2,2-disubstituted epoxides
02/28/2007EP1755640A1 Hybrid recombinases for genome manipulation
02/28/2007EP1507776B1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
02/28/2007EP1327143B1 Crystal structure of bace and uses thereof
02/28/2007EP1326995B8 Method for synthesising peptides, peptide mimetics and proteins
02/28/2007EP1317551B1 Human phospholipases and polynucleotides encoding the same
02/28/2007EP1268830B1 Cell cycle stress-related protein and methods of use in plants
02/28/2007EP1254240B1 Hybrid protease with reduced antigenicity and its use
02/28/2007EP1185631B9 Novel endo-beta-1,4-glucanases
02/28/2007EP1141205B1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in the active site loop region
02/28/2007EP1085811B1 Broad specificity dna damage endonuclease
02/28/2007EP1005557B1 High expression modules containing two or more tandem copies of a methioninase encoding sequence
02/28/2007EP0805855B1 Surfactant-based enzyme extraction process
02/28/2007EP0759083B1 Methods of inducing gene expression by ionizing radiation
02/28/2007EP0758390B1 Angiostatin and method of use for inhibition of angiogenesis
02/28/2007CN1922328A Method for producing L-amino acids from D-amino acids
02/28/2007CN1922315A Enzymatic synthesis, modification and decomposition of silicon(IV) compounds and other metal(IV) compounds
02/28/2007CN1922314A Fungall cell wall degrading enzyme
02/28/2007CN1922313A Acid alpha-glucosidase and fragments thereof
02/28/2007CN1922312A Multiple menace induced peroxidase promoter derived from sweet potato
02/28/2007CN1922311A Desaturase enzymes